- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Bioluminescence Ventures
BioCentury | Jan 3, 2025
Finance
Ausperbio, Gemmabio, Velavigo tap VCs for cash in late December
In BioCentury’s latest Venture Report, two trans-Pacific companies and a gene therapy newco draw funding
BioCentury | Jul 31, 2024
Management Tracks
Murray joins Bioluminescence
Plus: Terns names Elona Kogan chief legal officer, and updates from AiCuris and Anaveon
BioCentury | Jan 6, 2024
Management Tracks
Management moves abound on eve of JPM, including new chairs for Sobi, Corteria
Plus: Zaderej to retire as AxoGen CEO and updates from AxoGen, Delfi, Illumina, Evozyne, Kiyatec, Sosei, Twist, Novocure, Be Bio, Novo Holdings, Bioluminescence and more
BioCentury | Nov 1, 2023
Finance
New VC Bioluminescence believes downturn offers ripe opportunity for platform investing
The firm’s founder, Kouki Harasaki, draws upon lessons from 2008 to guide investment thesis in current environment
BioCentury | Sep 20, 2023
Finance
Sept. 19 Quick Takes: RNA editing company Airna emerges with $30M round led by Arch
Plus: Longevity-focused VC debuts and updates from Recode, Merck, Taysha and Paratek
BioCentury | Jul 20, 2023
Deals
July 19 Quick Takes: Argenx raises $1.1B on Vyvgart data
Plus: Surge raises $32M B round, Keytruda meets in cervical cancer and more
BioCentury | May 17, 2023
Emerging Company Profile
Nido Bio: treating neurodegeneration with small molecules
Debuting with $109M, 5AM Ventures-backed company developing small molecule corrector of a genetic neuromuscular disease
BioCentury | May 17, 2023
Finance
May 16 Quick Takes: Leaps by Bayer, RA Capital back Boundless in $100M series C
Plus: Prevail, Scribe in gene editing deal and updates from Ensoma, NewLimit and Drug Farm
Items per page:
1 - 8 of 8